EXCITE International (Excellence in Clinical Innovation and Technology Evaluation) convened high-level health care leaders at an inaugural multijurisdictional Summit on June 2-3 at the MaRS Discovery District, Toronto’s science, technology and innovation hub.
The Summit is the first comprehensive attempt to answer one of health technology’s most pressing challenges:
How do we accelerate the development and adoption of promising, disruptive new technologies so they reach the patient faster and more quickly impact the effectiveness and value of health care delivery?
Across the world, the introduction of new innovative health technologies is a complex process with many potential obstacles. Payers are often concerned with the possible overuse and rapid uptake of low value technologies and developers can be challenged by the long delays of getting a product to market. The journey of a new technology from initial concept to market comprises many steps and involves traditionally siloed stakeholders such as government, regulators, payers and health care systems. Further, new technologies are evaluated mostly when they come to market, so early opportunities for refinement are lost. Most importantly, the opportunity to positively and significantly affect patient outcomes can be stifled or delayed.
EXCITE International (EI) is attracting international interest to a new approach...
For the full report on the findings and discussions of the Summit, please review these resources:
TheEXCITEInternationalSummit-FindingsandDiscussionJuly302016.pdf
EI-Critical-Review-of-Explanatory-VS-Pragmatic-Trial-Design-Aug292016.pdf